vs
Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Ovintiv Inc. (OVV). Click either name above to swap in a different company.
Ovintiv Inc. is the larger business by last-quarter revenue ($2.1B vs $1.2B, roughly 1.7× Alignment Healthcare, Inc.). Ovintiv Inc. runs the higher net margin — 46.1% vs 0.9%, a 45.1% gap on every dollar of revenue. On growth, Ovintiv Inc. posted the faster year-over-year revenue change (-6.0% vs -74.7%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (34.6% CAGR vs -7.2%).
Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.
Ovintiv Inc. is a U.S. petroleum company based in Denver. The company was formed in 2020 through a restructuring of its Canadian predecessor, Encana.
ALHC vs OVV — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $2.1B |
| Net Profit | $11.4M | $946.0M |
| Gross Margin | — | — |
| Operating Margin | — | 21.2% |
| Net Margin | 0.9% | 46.1% |
| Revenue YoY | -74.7% | -6.0% |
| Net Profit YoY | — | 1676.7% |
| EPS (diluted) | — | $3.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.0B | $2.1B | ||
| Q3 25 | $993.7M | $2.0B | ||
| Q2 25 | $1.0B | $2.2B | ||
| Q1 25 | $926.9M | $2.4B | ||
| Q4 24 | $701.2M | $2.2B | ||
| Q3 24 | $692.4M | $2.2B | ||
| Q2 24 | $681.3M | $2.2B |
| Q1 26 | $11.4M | — | ||
| Q4 25 | $-11.0M | $946.0M | ||
| Q3 25 | $3.7M | $148.0M | ||
| Q2 25 | $15.7M | $307.0M | ||
| Q1 25 | $-9.1M | $-159.0M | ||
| Q4 24 | $-31.1M | $-60.0M | ||
| Q3 24 | $-26.4M | $507.0M | ||
| Q2 24 | $-24.0M | $340.0M |
| Q1 26 | — | — | ||
| Q4 25 | -1.0% | 21.2% | ||
| Q3 25 | 0.8% | 13.5% | ||
| Q2 25 | 2.2% | 23.1% | ||
| Q1 25 | -0.6% | -3.7% | ||
| Q4 24 | -3.2% | 0.1% | ||
| Q3 24 | -2.8% | 24.2% | ||
| Q2 24 | -2.7% | 25.4% |
| Q1 26 | 0.9% | — | ||
| Q4 25 | -1.1% | 46.1% | ||
| Q3 25 | 0.4% | 7.3% | ||
| Q2 25 | 1.5% | 13.9% | ||
| Q1 25 | -1.0% | -6.7% | ||
| Q4 24 | -4.4% | -2.7% | ||
| Q3 24 | -3.8% | 23.3% | ||
| Q2 24 | -3.5% | 15.5% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.04 | $3.64 | ||
| Q3 25 | $0.02 | $0.57 | ||
| Q2 25 | $0.07 | $1.18 | ||
| Q1 25 | $-0.05 | $-0.61 | ||
| Q4 24 | $-0.15 | $-0.22 | ||
| Q3 24 | $-0.14 | $1.92 | ||
| Q2 24 | $-0.13 | $1.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $705.6M | $280.0M |
| Total DebtLower is stronger | — | $5.2B |
| Stockholders' EquityBook value | $206.9M | $11.2B |
| Total Assets | $1.3B | $20.4B |
| Debt / EquityLower = less leverage | — | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $705.6M | — | ||
| Q4 25 | $604.2M | $280.0M | ||
| Q3 25 | $644.1M | $25.0M | ||
| Q2 25 | $503.8M | $20.0M | ||
| Q1 25 | $479.5M | $8.0M | ||
| Q4 24 | $470.6M | $42.0M | ||
| Q3 24 | $381.0M | $9.0M | ||
| Q2 24 | $363.7M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | $323.2M | $5.2B | ||
| Q3 25 | $322.7M | $5.2B | ||
| Q2 25 | $322.3M | $5.3B | ||
| Q1 25 | $321.9M | $5.5B | ||
| Q4 24 | $321.4M | $5.5B | ||
| Q3 24 | $212.0M | $5.9B | ||
| Q2 24 | $211.7M | $6.1B |
| Q1 26 | $206.9M | — | ||
| Q4 25 | $179.3M | $11.2B | ||
| Q3 25 | $161.9M | $10.2B | ||
| Q2 25 | $141.0M | $10.4B | ||
| Q1 25 | $108.1M | $10.1B | ||
| Q4 24 | $99.9M | $10.3B | ||
| Q3 24 | $114.5M | $10.7B | ||
| Q2 24 | $123.7M | $10.3B |
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.1B | $20.4B | ||
| Q3 25 | $1.1B | $19.4B | ||
| Q2 25 | $1.0B | $19.7B | ||
| Q1 25 | $895.6M | $19.6B | ||
| Q4 24 | $782.1M | $19.3B | ||
| Q3 24 | $692.3M | $19.9B | ||
| Q2 24 | $716.3M | $19.8B |
| Q1 26 | — | — | ||
| Q4 25 | 1.80× | 0.46× | ||
| Q3 25 | 1.99× | 0.51× | ||
| Q2 25 | 2.29× | 0.51× | ||
| Q1 25 | 2.98× | 0.55× | ||
| Q4 24 | 3.22× | 0.53× | ||
| Q3 24 | 1.85× | 0.55× | ||
| Q2 24 | 1.71× | 0.59× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $128.7M | $954.0M |
| Free Cash FlowOCF − Capex | — | $489.0M |
| FCF MarginFCF / Revenue | — | 23.8% |
| Capex IntensityCapex / Revenue | — | 22.6% |
| Cash ConversionOCF / Net Profit | 11.27× | 1.01× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.5B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $128.7M | — | ||
| Q4 25 | $-50.4M | $954.0M | ||
| Q3 25 | $144.6M | $812.0M | ||
| Q2 25 | $29.1M | $1.0B | ||
| Q1 25 | $16.6M | $873.0M | ||
| Q4 24 | $-8.7M | $1.0B | ||
| Q3 24 | $26.2M | $1.0B | ||
| Q2 24 | $23.5M | $1.0B |
| Q1 26 | — | — | ||
| Q4 25 | $-55.4M | $489.0M | ||
| Q3 25 | $139.1M | $268.0M | ||
| Q2 25 | $21.1M | $492.0M | ||
| Q1 25 | $8.4M | $256.0M | ||
| Q4 24 | $-18.0M | $468.0M | ||
| Q3 24 | $16.9M | $484.0M | ||
| Q2 24 | $11.8M | $398.0M |
| Q1 26 | — | — | ||
| Q4 25 | -5.5% | 23.8% | ||
| Q3 25 | 14.0% | 13.3% | ||
| Q2 25 | 2.1% | 22.2% | ||
| Q1 25 | 0.9% | 10.8% | ||
| Q4 24 | -2.6% | 21.4% | ||
| Q3 24 | 2.4% | 22.2% | ||
| Q2 24 | 1.7% | 18.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 22.6% | ||
| Q3 25 | 0.6% | 26.9% | ||
| Q2 25 | 0.8% | 23.5% | ||
| Q1 25 | 0.9% | 26.0% | ||
| Q4 24 | 1.3% | 25.3% | ||
| Q3 24 | 1.3% | 24.7% | ||
| Q2 24 | 1.7% | 28.4% |
| Q1 26 | 11.27× | — | ||
| Q4 25 | — | 1.01× | ||
| Q3 25 | 38.77× | 5.49× | ||
| Q2 25 | 1.86× | 3.30× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.02× | ||
| Q2 24 | — | 3.00× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALHC
Segment breakdown not available.
OVV
| Product And Service Revenue | $1.7B | 84% |
| Sales Of Purchased Product | $338.0M | 16% |
